| Product Code: ETC7660459 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel RNAI Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel RNAI Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel RNAI Therapeutics Market - Industry Life Cycle |
3.4 Israel RNAI Therapeutics Market - Porter's Five Forces |
3.5 Israel RNAI Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Israel RNAI Therapeutics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Israel RNAI Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Israel |
4.2.2 Growing investments in research and development of RNAi therapeutics |
4.2.3 Favorable government initiatives and regulatory support for RNAi therapeutics |
4.3 Market Restraints |
4.3.1 High costs associated with RNAi therapy development and manufacturing |
4.3.2 Stringent regulatory requirements for approval of RNAi therapeutics in Israel |
5 Israel RNAI Therapeutics Market Trends |
6 Israel RNAI Therapeutics Market, By Types |
6.1 Israel RNAI Therapeutics Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Israel RNAI Therapeutics Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Israel RNAI Therapeutics Market Revenues & Volume, By Intradermal Injections, 2021- 2031F |
6.1.4 Israel RNAI Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.1.5 Israel RNAI Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.1.6 Israel RNAI Therapeutics Market Revenues & Volume, By Intraperitoneal Injections, 2021- 2031F |
6.1.7 Israel RNAI Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel RNAI Therapeutics Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Israel RNAI Therapeutics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 Israel RNAI Therapeutics Market Revenues & Volume, By Research and Academic Laboratories, 2021- 2031F |
6.2.4 Israel RNAI Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Israel RNAI Therapeutics Market Import-Export Trade Statistics |
7.1 Israel RNAI Therapeutics Market Export to Major Countries |
7.2 Israel RNAI Therapeutics Market Imports from Major Countries |
8 Israel RNAI Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials for RNAi therapeutics in Israel |
8.2 Investment trends in RNAi therapeutics research and development |
8.3 Adoption rate of RNAi therapeutics by healthcare providers in Israel |
9 Israel RNAI Therapeutics Market - Opportunity Assessment |
9.1 Israel RNAI Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Israel RNAI Therapeutics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Israel RNAI Therapeutics Market - Competitive Landscape |
10.1 Israel RNAI Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel RNAI Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here